Chemical activators of C9orf5 include a range of compounds that initiate intracellular signaling cascades, resulting in the phosphorylation and subsequent activation of the protein. Forskolin, for instance, directly stimulates adenylate cyclase, thereby increasing cyclic AMP (cAMP) levels within the cell. The elevated cAMP activates protein kinase A (PKA), which is known to phosphorylate target proteins, including C9orf5. This phosphorylation can alter the protein's conformation and enhance its activity. Similarly, Dibutyryl cyclic AMP (dbcAMP) acts as a cAMP analog, diffusing into cells and activating PKA, which in turn can directly phosphorylate and activate C9orf5. Another activator, Phorbol 12-myristate 13-acetate (PMA), engages protein kinase C (PKC), a kinase that phosphorylates serine and threonine residues on numerous proteins. PKC, once activated, can phosphorylate C9orf5, leading to its activation.
Ionomycin, by increasing intracellular calcium levels, can activate calcium-dependent protein kinases which are capable of phosphorylating C9orf5, thereby enhancing its activity. Zinc Pyrithione, through a similar mechanism of elevating intracellular calcium, can also activate these calcium-dependent kinases, leading to the activation of C9orf5. Thapsigargin contributes to the activation of C9orf5 by inhibiting the SERCA pump, causing a rise in cytosolic calcium, which subsequently activates calcium-dependent kinases that can phosphorylate C9orf5. Okadaic Acid and Calyculin A, both protein phosphatase inhibitors, indirectly maintain C9orf5 in a phosphorylated and active state by preventing the dephosphorylation of the protein. Anisomycin and Epigallocatechin gallate (EGCG) activate the MAPK/ERK pathway, an important signaling mechanism that can lead to the activation of kinases that phosphorylate C9orf5. Lastly, Bisindolylmaleimide I and 4-Phorbol 12,13-didecanoate, through their modulation of PKC isoforms, can lead to the phosphorylation and activation of C9orf5, illustrating the diverse molecular interactions that converge on the activation of this specific protein.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin raises intracellular calcium levels which can activate calcium-dependent protein kinases that phosphorylate and activate C9orf5, enhancing its function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), which phosphorylates serine and threonine residues on proteins like C9orf5, resulting in their activation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG can activate a range of signaling pathways, such as MAPK, which might lead to the phosphorylation and activation of C9orf5. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic Acid inhibits protein phosphatases, which increases phosphorylation levels of proteins, including C9orf5, thus keeping it in an active state. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin activates the MAPK/ERK pathway, which could result in the activation of kinases that phosphorylate and activate C9orf5. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $47.00 | ||
Zinc Pyrithione can mobilize internal calcium stores, leading to the activation of calcium-dependent kinases that may phosphorylate and activate C9orf5. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
dbcAMP serves as a cell-permeable cAMP analog that activates PKA, which in turn can phosphorylate and thus activate C9orf5. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
Calyculin A inhibits protein phosphatases 1 and 2A, leading to an accumulation of phosphorylated proteins, including C9orf5, which results in its activation. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Bisindolylmaleimide I, as a selective PKC inhibitor, under specific conditions can activate certain PKC isoforms that could phosphorylate and activate C9orf5. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin inhibits the SERCA pump, causing a rise in cytosolic calcium levels, which activates calcium-dependent kinases, potentially leading to the activation of C9orf5. |